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To the Editor: We appreciate the report by Tsao and Chen1
about chylous ascites associated with the use of calcium channel
blockers in a patient on peritoneal dialysis. The authors list
other causes of chyloperitoneum, including neoplasia, nephrotic
syndrome, and congenital abnormalities of the lymphatic
system. We would like to bring to the readers’ attention
another disease associated with chylous ascites that may
be encountered in patients on peritoneal dialysis: systemic
lupus erythematosus.2 It has been suggested that mesenteric
inflammation from the lupus can lead to lymphatic obstruc-
tion and consequent chyloperitoneum and chylothorax.
Those managing patients on peritoneal dialysis should
be aware of this association between lupus and chylo-
peritoneum.
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Drs Graice and Bargman have indicated that mesenteric
inflammation from systemic lupus erythematosus can lead
to lymphatic obstruction, reflecting the diverse causes of
chylous ascites in peritoneal dialysis.1 We recently reported
on a 34-year-old woman with acute small-bowel infarction
as the presenting feature of lupus-associated protein-losing
enteropathy preceding a full-blown lupus flare.2 Our patient
had massive ascites; however, it was not chylous in nature.
The mechanistic basis remains unclear3 and the protean
manifestations may render clinical scenarios potentially
misleading, creating a great challenge in management of
patients with chyloperitoneum.
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